These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 15507764

  • 21. [Prospects for gene therapy for chronic granulomatous disease with gp91-phox deficiency].
    Nunoi H, Sugimoto Y, Kanegasaki S.
    Rinsho Ketsueki; 1998 Feb; 39(2):132. PubMed ID: 9545823
    [No Abstract] [Full Text] [Related]

  • 22. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.
    Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kühlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Lüthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M.
    Nat Med; 2006 Apr; 12(4):401-9. PubMed ID: 16582916
    [Abstract] [Full Text] [Related]

  • 23. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
    Rappa G, Anzanello F, Alexeyev M, Fodstad O, Lorico A.
    Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
    [Abstract] [Full Text] [Related]

  • 24. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
    Barese CN, Copelli SB, De Matteo E, Zandomeni R, Salgueiro F, Di Giovanni D, Heyworth P, Rivas EM.
    Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
    [Abstract] [Full Text] [Related]

  • 25. Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease.
    Goebel WS, Mark LA, Billings SD, Meyers JL, Pech N, Travers JB, Dinauer MC.
    J Invest Dermatol; 2005 Oct; 125(4):705-10. PubMed ID: 16185269
    [Abstract] [Full Text] [Related]

  • 26. Modern management of chronic granulomatous disease.
    Seger RA.
    Br J Haematol; 2008 Feb; 140(3):255-66. PubMed ID: 18217895
    [Abstract] [Full Text] [Related]

  • 27. Hematopoietic stem cell transplantation for chronic granulomatous disease.
    Seger RA.
    Immunol Allergy Clin North Am; 2010 May; 30(2):195-208. PubMed ID: 20493396
    [Abstract] [Full Text] [Related]

  • 28. American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.
    Kaiser J.
    Science; 2005 Jun 17; 308(5729):1735-6. PubMed ID: 15961648
    [No Abstract] [Full Text] [Related]

  • 29. Polyclonal long-term MFGS-gp91phox marking in rhesus macaques after nonmyeloablative transplantation with transduced autologous peripheral blood progenitor cells.
    Brenner S, Ryser MF, Choi U, Whiting-Theobald N, Kuhlisch E, Linton G, Kang E, Lehmann R, Rosen-Wolff A, Rudikoff AG, Farese AM, Macvittie TJ, Roesler J, Horwitz ME, Malech HL.
    Mol Ther; 2006 Aug 17; 14(2):202-11. PubMed ID: 16600688
    [Abstract] [Full Text] [Related]

  • 30. Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBB.
    Stasia MJ, Brion JP, Boutonnat J, Morel F.
    J Infect Dis; 2003 Nov 15; 188(10):1593-604. PubMed ID: 14624387
    [Abstract] [Full Text] [Related]

  • 31. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene.
    von Goessel H, Hossle JP, Seger R, Gungor T.
    Exp Hematol; 2006 Apr 15; 34(4):528-35. PubMed ID: 16569599
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Signed outside: a surface marker system for transgenic cytoplasmic proteins.
    Wohlgensinger V, Seger R, Ryan MD, Reichenbach J, Siler U.
    Gene Ther; 2010 Oct 15; 17(10):1193-9. PubMed ID: 20445581
    [Abstract] [Full Text] [Related]

  • 36. A splice-supporting intronic mutation in the last bp position of a cryptic exon within intron 6 of the CYBB gene induces its incorporation into the mRNA causing chronic granulomatous disease (CGD).
    Rump A, Rösen-Wolff A, Gahr M, Seidenberg J, Roos C, Walter L, Günther V, Roesler J.
    Gene; 2006 Apr 26; 371(2):174-81. PubMed ID: 16516412
    [Abstract] [Full Text] [Related]

  • 37. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
    Köker MY, Sanal O, de Boer M, Tezcan I, Metin A, Tan C, Ersoy F, Roos D.
    Eur J Clin Invest; 2006 Apr 26; 36(4):257-64. PubMed ID: 16620288
    [Abstract] [Full Text] [Related]

  • 38. Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs.
    Laugsch M, Rostovskaya M, Velychko S, Richter C, Zimmer A, Klink B, Schröck E, Haase M, Neumann K, Thieme S, Roesler J, Brenner S, Anastassiadis K.
    Mol Ther; 2016 Apr 26; 24(4):812-22. PubMed ID: 26316390
    [Abstract] [Full Text] [Related]

  • 39. A donor splice site mutation in intron 1 of CYBA, leading to chronic granulomatous disease.
    de Boer M, Hartl D, Wintergerst U, Belohradsky BH, Roos D.
    Blood Cells Mol Dis; 2005 Apr 26; 35(3):365-9. PubMed ID: 16157492
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.